Page results
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
The diabetes team have revisited their tips for managing diabetes over the Christmas holidays and updated them for 2022.
-
This page explains what patient-initiated follow-up (PIFU) involves after your treatment for endometrial (uterine or womb) cancer.
-
Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.
-
This information will give you an overview of BCG immunotherapy, how it is given and side effects it may cause.
-
The Adult Acute speech and language therapist (SLTs) work across a range of acute hospital specialities.
-
RNOH are pleased to launch a series of regular Health and Wellbeing Information and Support Sessions to support patients following a cancer diagnosis and also during/after treatment. These…
-
Five UCLH consultants have been elected Fellows of the Academy of Medical Sciences in recognition of their exceptional contributions to biomedical and health science and their ability to generate new knowledge and improve the health of people everywhere.
-
UCLH is reminding staff that gloves are not always required, by reducing the instances where non-sterile plastic gloves are used when treating non-infectious patients. The focus is now on how clean hands are just as effective a barrier against infection.
File results
-
FOI/2024/0148 - Cleaning audit system at Trust
-
FOI/2024/0149 - National Hospital for Neurology and Neurosurgery (NHNN) admissions 2018-2023
-
FOI/2024/0155 - Immunotherapy treatments for lung cancer
-
FOI/2024/0162 - Various technology systems/ services used at Trust
-
FOI/2024/0163 - Renal cell carcinoma and melanoma treatments
-
FOI/2024/0166 - Recruitment systems/CRM platform
-
FOI/2024/0171 - Dermatology consultants
-
FOI/2024/0172 - Patients excluded from care at the Trust 2010-2023
-
FOI/2024/0179 - Water usage/ procurement
-
FOI/2024/0183 - Immunology Hidradenitis Suppurativa (HS) treatment